Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Amgen revenue increased from $23.4 billion in 2019 to $25.4 billion in 2020, a (8.8%) increase.

Annual Revenue ($)

Amgen revenue was $25.42 b in FY, 2020 which is a (8.8%) year over year increase from the previous period.

Quarterly Revenue ($)

FY, 2018FY, 2019FY, 2020
Revenue$23.75 b$23.36 b$25.42 b
Q1, 2019Q2, 2019Q3, 2019Q1, 2020Q2, 2020Q3, 2020Q1, 2021Q2, 2021
Revenue$5.56 b$5.87 b$5.74 b$6.16 b$6.21 b$6.42 b$5.9 b$6.53 b

Annual Growth Rate (%)

Revenue Breakdown

Business Segment

Geographic Segment

Amgen revenue breakdown by business segment: 8.6% from Otezla, 25.9% from Other Products, 6.2% from Aranesp, 7.5% from XGEVA, 10.9% from Prolia, 9.0% from Neulasta, 19.7% from Enbrel and 12.3% from Other

Amgen revenue breakdown by geographic segment: 27.2% from Rest of World and 72.8% from United States

FY, 2020FY, 2019FY, 2018
Other Revenues$1.18 b$1.16 b$1.21 b
Other Products$6.57 b$4.96 b$4.31 b
Sensipar/Mimpara$551 m$1.77 b
EPOGEN$867 m$1.01 b
Aranesp$1.57 b$1.73 b$1.88 b
XGEVA$1.9 b$1.94 b$1.79 b
Prolia$2.76 b$2.67 b$2.29 b
Neulasta$2.29 b$3.22 b$4.48 b
Enbrel$5 b$5.23 b$5.01 b
KYPROLIS$1.07 b$1.04 b
Otezla$2.2 b
Repatha$887 m
FY, 2020FY, 2019FY, 2018
Rest of World$6.93 b$6.14 b$5.39 b
United States$18.5 b$17.22 b$18.36 b

Need Data?

Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.

Footer menu